PRRT2 and neoplasm: In particular, the phosphorylation of SHP-1 on the Ser591 residue by PKCθ supports a repressed SHP-1 state, while neutralization of PKCθ has been reported to preserve SHP-1 into an active conformation, reducing NK cell activation and cytotoxicity, thus promoting tumor progression in vivo.